ArticleBMC cancer2025
Bidirectional relationship between anxiety disorder and cancer: a longitudinal population-based cohort study.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Chronic psychological stress and gastric cancer: bidirectional associations, biological mechanisms, and clinical implications-a narrative review.Journal of gastrointestinal oncology · 2026Review
- Differential Use of Depression and Anxiety Medications in Adults With a History of Cancer.JAMA network open · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAlthough research has highlighted the link between anxiety and cancer, studies on the relationship between the two have produced inconsistent findings. Therefore, we investigated this relationship and also examined which types of cancer are more likely to induce anxiety.
methodsThis retrospective longitudinal cohort study, conducted in Taiwan from 2003 to 2016, looked at the risk of cancer in 23,255 patients with anxiety disorder and the risk of anxiety in 33,334 patients with cancer diagnosed between 2003 and 2005. For both analyses, a comparison cohort was created using 1:4 case-control sampling. Cox proportional hazard regression models were used to analyze factors related to anxiety disorder or cancer.
resultsPatients with anxiety were more likely to develop cancer (adjusted hazard ratio [AHR] = 1.29; 95% confidence interval [CI]: 1.23-1.35) compared to those in the comparison group. Particularly high risks were observed for thyroid cancer (AHR: 2.13, CI: 1.60-2.82), skin cancer (AHR: 2.10, CI: 1.63-2.71), and prostate cancer (AHR: 1.97, CI: 1.59-2.47). Patients with cancer were more likely to develop anxiety than those without cancer (AHR: 1.63, 95% CI: 1.56-1.71), with particularly high risks observed in those with nose cancer (AHR: 3.12, 95% CI: 2.41-4.03), leukemia (AHR: 2.54, 95% CI: 1.63-3.96), thyroid cancer (AHR: 2.34, 95% CI: 1.84-2.97), and oral cancer (AHR: 2.04, 95% CI: 1.65-2.52).
conclusionsOur findings highlight a bidirectional link between cancer and anxiety disorder. Understanding this two-way connection can help healthcare providers develop effective strategies for managing cancer and anxiety disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.